DAVITA INC. Net Income (Loss) Available to Common Stockholders, Diluted
DAVITA INC. (DVA) reported Net Income (Loss) Available to Common Stockholders, Diluted of $136.89 million for the 3-month period ending 2013-09-30, per its 10-Q filed 2013-11-06.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2013-11-06
- DAVITA INC. net income (loss) available to common stockholders, diluted for the quarter ending 2013-09-30 was $136.89M, a 5.41% decline year-over-year.
- DAVITA INC. net income (loss) available to common stockholders, diluted for the quarter ending 2013-06-30 was $254.12M, a 166.55% increase year-over-year.
- DAVITA INC. net income (loss) available to common stockholders, diluted for the quarter ending 2013-03-31 was $30.16M, a 78.47% decline year-over-year.
- DAVITA INC. net income (loss) available to common stockholders, diluted for the quarter ending 2012-12-31 was $155.84M, a 5.04% increase year-over-year.
- DAVITA INC. net income (loss) available to common stockholders, diluted for fiscal 2012 was $536.02M, a 12.06% increase from fiscal 2011.
- DAVITA INC. net income (loss) available to common stockholders, diluted for fiscal 2011 was $478.34M, a 17.93% increase from fiscal 2010.
- DAVITA INC. net income (loss) available to common stockholders, diluted for fiscal 2010 was $405.62M.
- DAVITA INC. net income (loss) available to common stockholders, diluted for fiscal 2008 was $374.16M.
| Period end | Net Income (Loss) Available to Common Stockholders, Diluted 3 month | Net Income (Loss) Available to Common Stockholders, Diluted 6 month | Net Income (Loss) Available to Common Stockholders, Diluted 9 month | Net Income (Loss) Available to Common Stockholders, Diluted 12 month |
|---|---|---|---|---|
| 2013-09-30 | $136.89M 10-Q · filed 2013-11-06 | $391.00M derived: sum of 2 quarters · filed 2013-11-06 | $421.17M 10-Q · filed 2013-11-06 | $577.01M derived: sum of 4 quarters · filed 2013-11-06 |
| 2013-06-30 | $254.12M 10-Q · filed 2013-08-07 | $284.28M 10-Q · filed 2013-08-07 | $440.12M derived: sum of 3 quarters · filed 2013-08-07 | $584.84M derived: sum of 4 quarters · filed 2013-11-06 |
| 2013-03-31 | $30.16M 10-Q · filed 2013-05-09 | $186.00M derived: sum of 2 quarters · filed 2013-05-09 | $330.72M derived: sum of 3 quarters · filed 2013-11-06 | $426.06M derived: sum of 4 quarters · filed 2013-11-06 |
| 2012-12-31 | $155.84M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | $300.56M derived: sum of 2 quarters · filed 2013-11-06 | $395.90M derived: sum of 3 quarters · filed 2013-11-06 | $536.02M 10-K · filed 2013-03-01 |
| 2012-09-30 | $144.72M 10-Q · filed 2013-11-06 | $240.06M derived: sum of 2 quarters · filed 2013-11-06 | $380.18M 10-Q · filed 2013-11-06 | $528.53M derived: sum of 4 quarters · filed 2013-11-06 |
| 2012-06-30 | $95.34M 10-Q · filed 2013-08-07 | $235.46M 10-Q · filed 2013-08-07 | $383.81M derived: sum of 3 quarters · filed 2013-08-07 | $519.16M derived: sum of 4 quarters · filed 2013-08-07 |
| 2012-03-31 | $140.12M 10-Q · filed 2013-05-09 | $288.48M derived: sum of 2 quarters · filed 2013-05-09 | $423.82M derived: sum of 3 quarters · filed 2013-05-09 | $523.93M derived: sum of 4 quarters · filed 2013-05-09 |
| 2011-12-31 | $148.35M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | $283.70M derived: sum of 2 quarters · filed 2013-03-01 | $383.81M derived: sum of 3 quarters · filed 2013-03-01 | $478.34M 10-K · filed 2013-03-01 |
| 2011-09-30 | $135.34M 10-Q · filed 2012-10-31 | $235.45M derived: sum of 2 quarters · filed 2012-10-31 | $329.98M 10-Q · filed 2012-10-31 | $398.98M derived: sum of 4 quarters · filed 2013-03-01 |
| 2011-06-30 | $100.11M 10-Q · filed 2012-08-03 | $194.64M 10-Q · filed 2012-08-03 | $263.63M derived: sum of 3 quarters · filed 2013-03-01 | $383.05M derived: sum of 4 quarters · filed 2013-03-01 |
| 2011-03-31 | $94.53M 10-Q · filed 2012-05-02 | $163.53M derived: sum of 2 quarters · filed 2013-03-01 | $282.94M derived: sum of 3 quarters · filed 2013-03-01 | $391.59M derived: sum of 4 quarters · filed 2013-03-01 |
| 2010-12-31 | $69.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | $188.41M derived: sum of 2 quarters · filed 2013-03-01 | $297.06M derived: sum of 3 quarters · filed 2013-03-01 | $405.62M 10-K · filed 2013-03-01 |
| 2010-09-30 | $119.41M 10-Q · filed 2011-11-04 | $228.06M derived: sum of 2 quarters · filed 2011-11-04 | $336.62M 10-Q · filed 2011-11-04 | $446.07M derived: sum of 4 quarters · filed 2012-07-06 |
| 2010-06-30 | $108.65M 10-Q · filed 2011-08-04 | $217.21M 10-Q · filed 2011-08-04 | $326.66M derived: sum of 3 quarters · filed 2012-07-06 | $437.59M derived: sum of 4 quarters · filed 2012-07-06 |
| 2010-03-31 | $108.55M 10-Q · filed 2011-05-06 | $218.01M derived: sum of 2 quarters · filed 2012-07-06 | $328.94M derived: sum of 3 quarters · filed 2012-07-06 | $434.76M derived: sum of 4 quarters · filed 2012-07-06 |
| 2009-12-31 | $109.46M derived: 8-K 12 month − 10-Q 9 month · filed 2012-07-06 | $220.39M derived: sum of 2 quarters · filed 2012-07-06 | $326.21M derived: sum of 3 quarters · filed 2012-07-06 | $422.42M 8-K · filed 2012-07-06 |
| 2009-09-30 | $110.93M 10-Q · filed 2010-11-05 | $216.75M derived: sum of 2 quarters · filed 2010-11-05 | $312.96M 10-Q · filed 2010-11-05 | |
| 2009-06-30 | $105.82M 10-Q · filed 2010-08-05 | $202.03M 10-Q · filed 2010-08-05 | ||
| 2008-12-31 | $374.16M 10-K · filed 2011-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |